Early research (Phase 1)Active Not RecruitingNCT04794699What this trial is testingStudy of IDE397 in Participants With Solid Tumors Harboring MTAP DeletionWho this might be right forSolid Tumor IDEAYA Biosciences 169
Early research (Phase 1)Not Yet RecruitingNCT07469982What this trial is testingA Phase I Study of SY-9453 in Patients With Advanced Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumors With Homozygous MTAP Deletion Shouyao Holdings (Beijing) Co. LTD 122
Testing effectiveness (Phase 2)Looking for participantsNCT06914128What this trial is testingA First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid TumorsWho this might be right forMTAP-deleted Solid Tumors Bayer 370
Early research (Phase 1)Looking for participantsNCT06968572What this trial is testingPhase I Study of HSK41959 in Solid Tumors With MTAP DeletionWho this might be right forAdvanced Solid Tumors Haisco Pharmaceutical Group Co., Ltd. 245
Early research (Phase 1)Looking for participantsNCT05245500What this trial is testingPhase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionWho this might be right forMesotheliomaNon Small Cell Lung CancerMalignant Peripheral Nerve Sheath Tumors+3 more Bristol-Myers Squibb 336
Not applicableStudy completedNCT03361358What this trial is testingPre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or LymphomaWho this might be right forAdvanced Solid TumorsLymphoma Agios Pharmaceuticals, Inc. 44
Early research (Phase 1)Active Not RecruitingNCT06568614What this trial is testingAn Investigational Study of BG-89894 Tablets in Participants With Advanced Solid TumorsWho this might be right forAdvanced or Metastatic MTAP-deleted Solid Tumors BeOne Medicines 29
Early research (Phase 1)Looking for participantsNCT06414460What this trial is testingStudy of ISM3412 in Participants With Locally Advanced/Metastatic Solid TumorsWho this might be right forLocally Advanced/Metastatic Solid Tumors InSilico Medicine Hong Kong Limited 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07492680What this trial is testingBMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)Who this might be right forSolid Tumors Bristol-Myers Squibb 260
Testing effectiveness (Phase 2)Looking for participantsNCT05732831What this trial is testingSafety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsWho this might be right forLocally Advanced Solid Tumor Tango Therapeutics, Inc. 225
Testing effectiveness (Phase 2)Looking for participantsNCT06188702What this trial is testingS095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAPWho this might be right forMTAP-deleted Solid Tumors Servier Bio-Innovation LLC 342
Early research (Phase 1)Looking for participantsNCT07277413What this trial is testingIDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsWho this might be right forNSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+8 more IDEAYA Biosciences 260
Early research (Phase 1)Looking for participantsNCT06973863What this trial is testingPEP08 in Patients With MTAP-Del Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorSolid TumorsMTAP-deleted Solid Tumors+1 more PharmaEngine 40
Early research (Phase 1)Looking for participantsNCT07077434What this trial is testingAssess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Bristol-Myers Squibb 32
Early research (Phase 1)Ended earlyNCT03435250What this trial is testingStudy of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP LossWho this might be right forAdvanced Solid TumorsLymphoma Institut de Recherches Internationales Servier 123
Early research (Phase 1)Looking for participantsNCT07128303What this trial is testingStudy of GS-5319 in Adults With Solid TumorsWho this might be right forAdvanced Solid Tumor Gilead Sciences 178
Early research (Phase 1)Looking for participantsNCT06796699What this trial is testingA Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors With MTAP Gene Deletion Suzhou Genhouse Bio Co., Ltd. 90
Early research (Phase 1)Looking for participantsNCT07532902What this trial is testingBMS-986504 With Standard-of-Care Therapy for People With Solid Tumor CancerWho this might be right forDiffuse Pleural MesotheliomaGastroesophageal CarcinomaUrothelial Carcinoma Memorial Sloan Kettering Cancer Center 60
Early research (Phase 1)Looking for participantsNCT06672523What this trial is testingEvaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase DeletionWho this might be right forAdvanced Solid Tumors With Homozygous MTAP Deletion Bristol-Myers Squibb 8
Testing effectiveness (Phase 2)Ended earlyNCT05275478What this trial is testingSafety and Tolerability of TNG908 in Patients With MTAP-deleted Solid TumorsWho this might be right forLocally Advanced Solid Tumor Tango Therapeutics, Inc. 110